在大鼠生理和病理心肌细胞缩过程中,谷氨酸酸乙酸转胺酶2的变化
Xin Liu1, Xiaolu Li2, Haotan Zhou3
1Department of Pediatric Cardiac Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China. 18811563661@163.com.
BMC cardiovascular disorders
|December 5, 2023
概括
谷氨酸酸转胺酶 (GOT) 水平在老鼠心肌生长方面有所不同. GOT2蛋白在正常生长中增加,但在病理性缩中减少,这表明GOT2蛋白在心脏病中起着调节作用.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 生理学 生理学 生理学
背景情况:
- 生理和病理心肌细胞缩是先天性心脏病的关键.
- 谷氨酸氧酸转胺酶 (GOT) 表示心肌损伤.
- 调查大鼠心肌细胞缩期间的GOT变化.
研究的目的:
- 在老鼠的生理和病理心肌细胞缩期间检查GOT mRNA,活性和GOT2蛋白水平.
- 了解GOT在与先天性心脏病相关的腹腔缩中的作用.
主要方法:
- 对GOTmRNA和活性进行RNA测序和色度测试.
- 对于GOT2蛋白质,西面涂抹和免疫光.
- 心肌细胞形态学的组织学方法 (H&E,WGA).
主要成果:
- GOT mRNA,活性和GOT2蛋白随着年龄相关的生理学缩在幼鼠中增加.
- 在缺氧诱导的病理性缩中,GOT2蛋白水平下降.
- 在GOT2表达的显著差异与高型相关.
结论:
- GOT2可能在老鼠的生理和病理心肌缩中发挥调节作用.
- 降低GOT2水平可能导致病理性缩和随后的心力衰竭.
- 研究结果表明GOT2是心脏病的潜在治疗点.
相关概念视频
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:26Cellular Adaptation II: Hypertrophy
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...